These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 34169786)

  • 1. Authors' Reply: A Crystal-Independent Role for Uric Acid in AKI Associated with Tumor Lysis Syndrome.
    Zafrani L; Mooney N
    J Am Soc Nephrol; 2023 Jan; 34(1):176-177. PubMed ID: 36719149
    [No Abstract]   [Full Text] [Related]  

  • 2. Daily serum phosphate increase as early and reliable indicator of kidney injury in children with leukemia and lymphoma developing tumor lysis syndrome.
    Biró E; Erdélyi D; Varga P; Sinkó M; Bartyik K; Kovács G; Ottóffy G; Vincze F; Szegedi I; Kiss C; Szabó T
    Pediatr Nephrol; 2023 Sep; 38(9):3117-3127. PubMed ID: 36943467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Crystal-Independent Role for Uric Acid in AKI Associated with Tumor Lysis Syndrome.
    Ejaz AA; Mohandas R; Beaver TM; Johnson RJ
    J Am Soc Nephrol; 2023 Jan; 34(1):175. PubMed ID: 36719148
    [No Abstract]   [Full Text] [Related]  

  • 4. The tumor lysis syndrome.
    Elinoff JM; Salit RB; Ackerman HC
    N Engl J Med; 2011 Aug; 365(6):571-2; author reply 573-4. PubMed ID: 21830982
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between uric acid and kidney function in adults at risk for tumor lysis syndrome.
    May HP; Mara KC; Barreto EF; Leung N; Habermann TM
    Leuk Lymphoma; 2021 Dec; 62(13):3152-3159. PubMed ID: 34169786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis.
    Lopez-Olivo MA; Pratt G; Palla SL; Salahudeen A
    Am J Kidney Dis; 2013 Sep; 62(3):481-92. PubMed ID: 23684124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis.
    Goldman SC; Holcenberg JS; Finklestein JZ; Hutchinson R; Kreissman S; Johnson FL; Tou C; Harvey E; Morris E; Cairo MS
    Blood; 2001 May; 97(10):2998-3003. PubMed ID: 11342423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Dose Rasburicase Might Be Adequate To Overcome Tumor Lysis Syndrome In Hematological Malignancies.
    Yaman S; Başcı S; Turan G; Ulu BU; Yiğenoğlu TN; Dal MS; Kızıl Çakar M; Altuntaş F
    Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):e71-e76. PubMed ID: 34565690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed, low-dose rasburicase for the treatment or prevention of hyperuricemia in adult oncology patients.
    Herrington JD; Dinh BC
    J Oncol Pharm Pract; 2015 Apr; 21(2):111-7. PubMed ID: 24549060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project.
    Russo E; Viazzi F; Pontremoli R; Barbagallo CM; Bombelli M; Casiglia E; Cicero AFG; Cirillo M; Cirillo P; Desideri G; D'Elia L; Ferri C; Galletti F; Gesualdo L; Giannattasio C; Iaccarino G; Leoncini G; Mallamaci F; Maloberti A; Masi S; Mengozzi A; Mazza A; Muiesan ML; Nazzaro P; Palatini P; Parati G; Rattazzi M; Rivasi G; Salvetti M; Tikhonoff V; Tocci G; Ungar A; Verdecchia P; Virdis A; Volpe M; Grassi G; Borghi C;
    J Nephrol; 2022 Jan; 35(1):211-221. PubMed ID: 33755930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?
    Khurana A; Mwangi R; Nowakowski GS; Habermann TM; Ansell SM; LaPlant BR; Link BK; Cerhan JR; Maurer MJ; Witzig TE
    J Clin Oncol; 2021 May; 39(15):1641-1649. PubMed ID: 33529046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease.
    Sellmayr M; Hernandez Petzsche MR; Ma Q; Krüger N; Liapis H; Brink A; Lenz B; Angelotti ML; Gnemmi V; Kuppe C; Kim H; Bindels EMJ; Tajti F; Saez-Rodriguez J; Lech M; Kramann R; Romagnani P; Anders HJ; Steiger S
    J Am Soc Nephrol; 2020 Dec; 31(12):2773-2792. PubMed ID: 32938648
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.